SB 898 requires Maryland’s Medical Assistance Program to reimburse applied behavior analysis (ABA) services provided by registered behavior technicians (RBTs) to Medicaid recipients diagnosed with autism spectrum disorder. The bill prohibits the state health department from mandating a specific certification (e.g., from the Behavior Analyst Certification Board) as a condition for reimbursement, except for a 150-day transition period during which RBTs must obtain certification. This directly affects Medicaid beneficiaries with autism and RBTs who deliver ABA services under supervision of certified professionals, streamlining access to care without immediate certification barriers. The law takes effect October 1, 2026, and applies prospectively only.
SB 496 would authorize Maryland's Medical Assistance Program (Medicaid) to cover comprehensive obesity treatment starting January 1, 2027. This includes intensive behavioral therapy, bariatric surgery, and FDA-approved weight management medications for eligible Medicaid recipients. The bill requires the Department of Health to notify program recipients if it chooses to implement this coverage and mandates a report to legislative committees by November 2027 on whether coverage has begun. The law takes effect October 1, 2026, but coverage for obesity treatment becomes available the following year.
SB 532 requires Maryland public senior colleges (like University System institutions) and community colleges to provide students with access to all over-the-counter contraception methods (such as condoms or emergency contraception) on campus through health centers, retail stores, or vending machines. Starting September 1, 2026, these institutions must submit annual reports to the Maryland Higher Education Commission detailing how access is provided, whether all methods are available, quantities distributed, and student consultation efforts. The Commission then reports this aggregated data to the Maryland General Assembly annually by October 1. The bill applies specifically to community colleges and public senior institutions (excluding specialized units like the University of Maryland Center for Environmental Science), effective July 1, 2026.
HB 1087 requires Maryland health care facilities performing surgeries that generate surgical smoke (like hospitals, ambulatory surgical centers, and freestanding medical facilities) to adopt policies mandating the use of smoke evacuation systems by January 1, 2028. These systems must capture and filter harmful surgical smoke particles at the source before they reach medical staff or patients. The bill defines "surgical smoke" as the gaseous byproducts from energy-generating surgical tools, including bio-aerosols and lung-damaging particles. This policy change aims to protect health care workers and patients from exposure to potentially hazardous smoke during procedures.
SB 794 creates a special enrollment period for pregnancy in Maryland health insurance. It allows individuals who become pregnant (confirmed by a healthcare provider) to choose whether their coverage starts on the first day of the month they receive pregnancy confirmation or the first day of the following month. If they don’t select a date, the insurance company must choose one of these two options. This applies to both marketplace and non-marketplace health plans and takes effect January 1, 2027. The bill directly affects pregnant individuals and parents enrolling dependents during this 90-day special enrollment period.
This bill requires Maryland's Office of the Comptroller, with assistance from the Department of Human Services, to conduct a feasibility study on creating a program that would provide monthly payments to caregivers of specific family members. The study will examine economic impacts like potential increases in workforce participation, tax revenue, and reduced reliance on public benefits, while also identifying funding sources and administrative costs. It must be completed by July 1, 2027, and reported to relevant legislative committees. The bill does not establish the program itself but sets the groundwork for evaluating its potential. This study directly affects state agencies responsible for conducting the analysis, with no direct impact on caregivers or families until a future decision to implement the program.
SB 892 modifies Maryland's State Advisory Council on Health and Wellness to include a member with expertise in perimenopausal, menopausal, and postmenopausal care. It requires health occupations boards (like those for nurses or doctors) to grant at least two continuing education credits for every hour of training on these conditions, directly affecting healthcare professionals renewing their licenses. The bill also mandates the Maryland Health Care Commission, Commission for Women, and Department of Health to take specific actions related to these health conditions. These changes aim to improve provider knowledge and care for women experiencing these common health transitions.
SB 839 requires Maryland's Department of Health to conduct a survey of pharmacy dispensing costs in the state every three years starting in 2026. Within six months after each survey, the Department must establish a fee charged to pharmacies for dispensing drugs under the state's Medical Assistance Program (Medicaid). This fee will be based directly on the survey results, aiming to reflect actual dispensing costs. The bill applies specifically to pharmacies participating in Maryland's Medicaid program and takes effect October 1, 2026.
HB 1249 prohibits certified recovery residences in Maryland from refusing services to individuals receiving medication-assisted treatment (MAT) for opioid use disorder or requiring them to stop or change their MAT as a condition for housing. The bill amends certification standards for recovery residences (which provide non-clinical housing for people with substance use disorders) to ensure credentialing entities cannot allow such discrimination. It directly affects certified recovery residences and individuals using MAT for opioid addiction, requiring certification rules to explicitly ban these practices. The law takes effect October 1, 2026, and applies only to opioid use disorder treatment under MAT.
HB 1470 requires Maryland's Department of Health to conduct an in-state cost-of-dispensing survey for Medicaid drugs at least once every three years, starting in 2026. Within six months after each survey, the Department must set a fee-for-service reimbursement rate for pharmacists dispensing Medicaid-covered drugs based on the survey results. This directly affects pharmacies participating in Maryland's Medical Assistance Program (Medicaid), as the new fee structure will determine their reimbursement for drug dispensing services. The bill establishes a regular, data-driven process to update these fees, ensuring they reflect actual dispensing costs.